The non-immunosuppressive Cyclosporin A analogue Debio-025 is a potent inhibitor of Hepatitis C virus replication in vitro | Debio 025 | /

Home|Careers|Contact us

News

20.11.2008
Debiopharm and Aurigene sign licensing agreement for the development and commercialisation of Debio 0617, a novel inhibitor of an undisclosed oncology pathway
17.11.2008
Debiopharm and Pharmaleads sign license agreement for Debio 0827 or PL37 in treatment of chronic pain conditions

The non-immunosuppressive Cyclosporin A analogue Debio-025 is a potent inhibitor of Hepatitis C virus replication in vitro

Paeshuyse J, Kaul A, De Clercq E, Rosenwirth B, Dumont JM, Scalfaro P, Bartenschlager R, Neyts J. (abstract)

2nd VIRGIL International Symposium on Antiviral Drug Resistance - May 2006 - Lyon/France Hepatology 43: 761-770, April 2006

57th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) - Oct 2006 - Boston/USA : Hepatology, 2006. 346A. Vol. 44. number 4, Suppl. 1.